期刊文献+

慢性肾脏病与血管内皮细胞功能的研究进展 被引量:5

Research progress of vascular endothelial function in chronic kidney disease
下载PDF
导出
摘要 血管内皮细胞的功能改变与慢性肾脏病(CKD)的发生和发展密切相关。由血管内皮细胞功能失调引起的心血管疾病是CKD患者常见的并发症,同时也是患者死亡的重要原因。目前治疗血管内皮功能异常的主要方法是在控制原发疾病的基础上,运用减轻和修复血管内皮损伤的抗氧化药物。由于受多种因素影响,透析对血管内皮细胞功能的改善作用尚有一定局限性。采用基因治疗或细胞移植等新型治疗方法,结合现有治疗策略,改善血管内皮细胞功能或增强其再生能力,可减少CKD患者心血管事件的发生,降低患者病死率。 The changes of vascular endothelial function are closely related to the development of chronic kidney disease(CKD).Cardiovascular diseases caused by vascular endothelial dysfunction are the common complications of CKD,and are important causes of mortality in patients with CKD.Based on the control of primary diseases,antioxidant drugs that ameliorate the vascular endothelial injury are now applied in the treatment of vascular endothelial dysfunction.The improvement of vascular endothelial function brought by dialysis is limited to some extent due to many influencing factors.New strategies such as gene therapy and cell transplantation,together with treatment available,may improve function and regeneration of vascular endothelial cells,reduce cardiovascular events,and decrease the mortality of patients with CKD.
作者 张霞 金惠敏
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2012年第4期528-532,共5页 Journal of Shanghai Jiao tong University:Medical Science
关键词 血管内皮细胞 慢性肾脏病 抗氧化药物 透析 基因治疗 细胞移植 vascular endothelial cell chronic kidney disease antioxidant drug dialysis gene therapy cell transplantation
  • 相关文献

参考文献35

  • 1Malyszko J.Mechanism of endothelial dysfunction in chronic kidneydisease[J].Clin Chim Acta,2010,411(19-20):1412-1420. 被引量:1
  • 2Schwartz BG,Economides C,Mayeda GS,et al.The endothelialcell in health and disease:its function,dysfunction,measurementand therapy[J].Int J Impot,2010,22(2):77-90. 被引量:1
  • 3Wong WT,Wong SL,Tian XY,et al.Endothelial dysfunction:thecommon consequence in diabetes and hypertension[J].J CardiovascPharmacol,2010,55(4):300-307. 被引量:1
  • 4Schulz E,Jansen T,Wenzel P,et al.Nitric oxide,tetrahydrobiop-terin,oxidative stress,and endothelial dysfunction in hypertension[J].Antioxid Redox Signal,2008,10(6):1115-1126. 被引量:1
  • 5Diaz-Buxo JA,Woods HF.Protecting the endothelium:A new focusfor management of chronic kidney disease[J].Hemodial Int,2006,10(1):42-48. 被引量:1
  • 6Filiopoulos V,Vlassopoulos D.Inflammatory syndrome in chronickidney disease:pathogenesis and influence on outcomes[J].Inflamm Allergy Drug Target,2009,8(5):369-382. 被引量:1
  • 7Merino A,Nogueras S,Buendia P,et al.Microinflammation andendothelial damage in hemodialysis[J].Contrib Nephrol,2008,161:83-88. 被引量:1
  • 8Nacci C,Tarquinio M,Montagnani M.Molecular and clinicalaspects of endothelial dysfunction in diabetes[J].Intern EmergMed,2009,4(2):107-116. 被引量:1
  • 9Oyama T,Miyasita Y,Watanabe H,et al.The role of polyol path-way in high glucose-induced endothelial cell damages[J].DiabetesRes Clin Pract,2006,73(3):227-234. 被引量:1
  • 10Yamagishi S,Ueda S,Okuda S.A possible involvement of crosstalkbetween advanced glycation end products(AGEs)and asymmetricdimethylarginine(ADMA),an endogenous nitric oxide synthase inhi-bitor in accelerated atherosclerosis in diabetes[J].Med Hypotheses,2007,69(4):922-924. 被引量:1

同被引文献46

引证文献5

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部